Cyxone AB
CYXO | ST
Overview
Corporate Details
- ISIN(s):
- SE0007815428 (+2 more)
- LEI:
- 54930034OH16ROAY4K87
- Country:
- Sweden
- Address:
- Hyllie Boulevard 34, 215 32 Malmö
- Website:
- https://www.cyxone.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Cyxone AB develops disease-modifying therapies for autoimmune diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cyxone AB filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Cyxone AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cyxone AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-06-28 | Carl Magnus Högerkorp | Other | Buy | 64,950 | 40,788.60 SEK |
| 2023-06-27 | Carl Magnus Högerkorp | Other | Buy | 6,050 | 3,690.50 SEK |
| 2023-03-03 | Carl Magnus Högerkorp | Other | Buy | 100,010 | 51,005.10 SEK |
| 2023-03-02 | Carl Magnus Högerkorp | Other | Buy | 10,873 | 5,653.96 SEK |
| 2021-07-15 | Bert Junno | Other | Other | 1,788,732 | 7,763,096.88 SEK |
| 2021-07-15 | Bert Junno | Other | Other | 1,788,732 | N/A |
| 2021-07-14 | Bert Junno | Other | Other | 1,788,786 | 7,790,163.03 SEK |
| 2021-07-14 | Bert Junno | Other | Other | 1,788,786 | N/A |
| 2021-07-12 | Mikeoo Holding AB | Other | Other | 1,788,732 | 7,441,125.12 SEK |
| 2021-07-12 | Mikael Lindstam | Other | Other | 1,788,732 | N/A |
Peer Companies
Company
Country
Ticker
View
Develops microbiome-modulating ingredients and supplements to manage chronic lifestyle diseases.
United Kingdom
OPTI
United Kingdom
OPTI
Develops precision blood tests using 3D genomics for cancer diagnosis and therapy guidance.
United Kingdom
OBD
United Kingdom
OBD
De-risks oncology drug development for pharma/biotech using modeling and simulation.
United Kingdom
PYC
United Kingdom
PYC
Clinical-stage biopharma developing a first-in-class oral drug for diabetes and obesity.
Sweden
PILA
Sweden
PILA
AI-led biopharma developing drugs for high-need diseases like CRS and metabolic disorders.
United Kingdom
POLB
United Kingdom
POLB
CRO providing proteomics services & TMT® tags to biopharma for drug discovery & biomarkers.
United Kingdom
PRM
United Kingdom
PRM
Develops & licenses Fruitflow®, a patented ingredient for heart health in food & supplements.
United Kingdom
PXS
United Kingdom
PXS
United Kingdom
QUBE
R&D firm using AI and quantum computing to create efficient technologies for Bitcoin mining.
United Kingdom
QBT
United Kingdom
QBT